HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lorenzo Di Cesare Mannelli Selected Research

Phaseolus vulgaris alpha-amylase inhibitor (phaseolamin)

1/2022Phaseolus vulgaris extract ameliorates high-fat diet-induced colonic barrier dysfunction and inflammation in mice by regulating peroxisome proliferator-activated receptor expression and butyrate levels.
1/2019Phaseolus vulgaris L. Extract: Alpha-Amylase Inhibition against Metabolic Syndrome in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lorenzo Di Cesare Mannelli Research Topics

Disease

80Pain (Aches)
04/2024 - 09/2010
59Neuralgia (Stump Neuralgia)
04/2024 - 01/2009
33Hypersensitivity (Allergy)
06/2023 - 07/2013
30Neoplasms (Cancer)
10/2023 - 01/2013
16Hyperalgesia
11/2023 - 01/2009
13Inflammation (Inflammations)
12/2023 - 01/2013
13Osteoarthritis
06/2023 - 01/2013
12Colitis
10/2023 - 12/2019
11Rheumatoid Arthritis
06/2023 - 01/2013
10Chronic Pain
10/2023 - 07/2013
9Visceral Pain
10/2023 - 12/2019
9Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 03/2012
7Painful Neuropathy
09/2018 - 06/2014
6Gliosis
10/2023 - 01/2013
6Arthritis (Polyarthritis)
10/2022 - 01/2016
6Colonic Neoplasms (Colon Cancer)
02/2018 - 01/2014
5Hypertension (High Blood Pressure)
06/2021 - 06/2009
4Wounds and Injuries (Trauma)
01/2023 - 07/2013
4Brain Ischemia (Cerebral Ischemia)
01/2022 - 10/2005
4Abdominal Pain (Pain, Abdominal)
12/2020 - 12/2016
3Edema (Dropsy)
12/2023 - 01/2014
3Ischemia
12/2023 - 04/2016
3Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2023 - 01/2017
3Nervous System Diseases (Neurological Disorders)
12/2022 - 12/2017
3Cognitive Dysfunction
12/2022 - 01/2018
3Body Weight (Weight, Body)
08/2022 - 01/2019
3Neuroinflammatory Diseases
07/2022 - 10/2021
3Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022 - 01/2019
3Neuroblastoma
11/2019 - 04/2018
3Pancreatic Neoplasms (Pancreatic Cancer)
03/2019 - 01/2016
3Hypoxia (Hypoxemia)
12/2018 - 05/2015
3Neoplasm Metastasis (Metastasis)
09/2018 - 05/2015
3Peripheral Nervous System Diseases (PNS Diseases)
04/2016 - 08/2007

Drug/Important Bio-Agent (IBA)

52Oxaliplatin (Eloxatin)FDA LinkGeneric
05/2023 - 03/2012
21Carbonic Anhydrases (Carbonic Anhydrase)IBA
10/2022 - 04/2015
16Protein Isoforms (Isoforms)IBA
12/2021 - 04/2015
13Opioid Analgesics (Opioids)IBA
01/2024 - 09/2015
122,4-dinitrofluorobenzene sulfonic acidIBA
10/2023 - 12/2019
12Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
12/2022 - 01/2009
10AntioxidantsIBA
06/2021 - 03/2012
9Morphine (MS Contin)FDA LinkGeneric
01/2024 - 01/2015
8Proteins (Proteins, Gene)FDA Link
04/2022 - 05/2014
8LigandsIBA
01/2022 - 12/2011
7Analgesics (Analgesic Drugs)IBA
04/2024 - 01/2016
7CarrageenanIBA
12/2023 - 01/2013
7Paclitaxel (Taxol)FDA LinkGeneric
11/2023 - 11/2015
6Streptozocin (Streptozotocin)FDA Link
10/2023 - 04/2011
6Acetylcarnitine (Alcar)IBA
10/2023 - 08/2007
6Thioctic Acid (Lipoic Acid)IBA
06/2021 - 01/2013
5Pregabalin (Lyrica)FDA Link
10/2023 - 04/2011
5Sulfonic AcidsIBA
10/2023 - 01/2020
5SodiumIBA
12/2022 - 01/2013
5Glutamic Acid (Glutamate)FDA Link
12/2022 - 10/2005
5Antineoplastic Agents (Antineoplastics)IBA
10/2021 - 07/2013
5Purinergic P1 Receptors (Adenosine Receptor)IBA
10/2021 - 01/2019
5Carbonic Anhydrase InhibitorsIBA
05/2021 - 04/2015
5PlatinumIBA
01/2021 - 11/2014
5SulfonamidesIBA
09/2019 - 04/2015
5Freund's AdjuvantIBA
06/2019 - 01/2013
5isothiocyanic acidIBA
03/2019 - 11/2016
42,4-dinitrobenzeneIBA
10/2023 - 01/2020
4dimiracetamIBA
12/2022 - 06/2014
4LipopolysaccharidesIBA
12/2022 - 08/2019
4Potassium Channels (Potassium Channel)IBA
02/2022 - 11/2016
4GlucosinolatesIBA
02/2022 - 11/2018
4N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA
01/2022 - 01/2020
42,4-dinitrobenzenesulfonic acidIBA
01/2022 - 01/2020
4Carbonic Anhydrase IXIBA
12/2021 - 11/2017
4BenzenesulfonamidesIBA
01/2021 - 12/2018
4Neuroprotective AgentsIBA
01/2021 - 01/2009
4Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
12/2020 - 01/2017
4Gabapentin (Neurontin)FDA LinkGeneric
04/2018 - 07/2015
3Monoclonal AntibodiesIBA
04/2024 - 01/2018
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2024 - 01/2018
3palmidrolIBA
04/2024 - 02/2022
3Hydrogen Sulfide (Sulfide, Hydrogen)IBA
12/2023 - 07/2017
3erucinIBA
12/2023 - 03/2019
3DDD-028IBA
11/2023 - 01/2021
3Duloxetine Hydrochloride (Cymbalta)FDA Link
10/2023 - 09/2015
3Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
06/2023 - 01/2020
3Liposomes (Liposome)IBA
05/2023 - 11/2015
3EndocannabinoidsIBA
05/2023 - 12/2020
3Conotoxins (Conotoxin)IBA
12/2022 - 10/2014
3glucoraphaninIBA
08/2022 - 11/2018
3Dexamethasone (Maxidex)FDA LinkGeneric
05/2022 - 01/2020
3AcidsIBA
01/2022 - 12/2011
3Cadmium Chloride (Cadmium Dichloride)IBA
01/2022 - 04/2018
3IsothiocyanatesIBA
04/2021 - 07/2017
3Opioid Receptors (Opioid Receptor)IBA
01/2020 - 11/2015
3Ibuprofen (Motrin)FDA LinkGeneric
06/2019 - 07/2015
3NociceptinIBA
03/2018 - 11/2015

Therapy/Procedure

25Therapeutics
02/2022 - 07/2013
22Drug Therapy (Chemotherapy)
04/2024 - 07/2013
6Ligation
01/2021 - 08/2007
5Intra-Articular Injections
06/2023 - 07/2015
5Aftercare (After-Treatment)
12/2022 - 05/2014
5Oral Administration
12/2022 - 10/2017
4Analgesia
01/2020 - 05/2011
3Laser Therapy (Surgery, Laser)
05/2023 - 11/2017
3Injections
01/2023 - 01/2018